American Journal of Hypertension

American Journal of Hypertension  
Former name
Journal of Clinical Hypertension
Abbreviated title (ISO 4)
Am. J. Hypertens.
Discipline Cardiovascular medicine
Language English
Edited by Michael H. Alderman
Publication details
Publisher
Publication history
1985-present
Frequency Monthly
3.402
Indexing
ISSN 0895-7061 (print)
1941-7225 (web)
CODEN AJHYE6
OCLC no. 16748912
Links

The American Journal of Hypertension is a monthly peer-reviewed medical journal covering the field of cardiovascular medicine. It is published by Oxford University Press and the editor-in-chief is Michael H. Alderman (Albert Einstein College of Medicine). According to the Journal Citation Reports, the journal has a 2013 impact factor of 3.402, ranking it 20th out of 65 journals in the category "Peripheral Vascular Disease".[1]

History

It was established in 1985 as the Journal of Clinical Hypertension, obtaining its current name in 1988.[2][3] It was originally published quarterly by Elsevier,[2] which transferred it to Nature Publishing Group beginning in 2008,[4][5] but the journal is now published monthly by Oxford University Press,[3] which acquired the journal in 2012. Oxford University Press' first issue of the journal was published in January 2013.[6]

Controversial salt research

In 2011, a meta-analysis published in the journal found no strong evidence that reducing salt consumption decreased all-cause mortality or cardiovascular morbidity.[7][8] Its conclusions were at odds with those of previously conducted observational studies, which some researchers suggested was because the new meta-analysis did not look at enough patients.[9]

In March 2014, another meta-analysis was published in the journal which found that reduced salt consumption and increased salt consumption, relative to the typical amount consumed by Americans, were associated with increased mortality.[10] The study proved controversial because it found that the level of salt consumption associated with the best health outcomes was between 2,645 and 4,945 mg/day, which is much higher than the CDC's recommendations.[11] The American Heart Association criticized the study, saying that it "relied on flawed data."[12]

References

  1. "Journals Ranked by Impact: Peripheral Vascular Disease". 2013 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2014.
  2. 2.0 2.1 "Journal of clinical hypertension". NLM Catalog. Retrieved 23 November 2014.
  3. 3.0 3.1 "American journal of hypertension". NLM Catalog. Retrieved 23 November 2014.
  4. Clarke, Maxine (31 January 2008). "American Journal of Hypertension at NPG". Nautilus Blog. Nature. Retrieved 23 November 2014.
  5. "Journal Transfers". ScienceDirect. Retrieved 23 November 2014.
  6. "Oxford University Press acquires American Journal of Hypertension". Oxford University Press. 28 August 2012. Archived from the original on 22 January 2014. Retrieved 23 November 2014.
  7. Taylor, RS; Ashton, KE; Moxham, T; Hooper, L; Ebrahim, S (August 2011). "Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review).". American journal of hypertension 24 (8): 843–53. doi:10.1038/ajh.2011.115. PMID 21731062.
  8. Moyer, Melinda (8 July 2011). "It's Time to End the War on Salt". Scientific American. Retrieved 24 November 2014.
  9. Callaway, Ewen (6 July 2011). "Review adds salt to a familiar concern". Nature News. doi:10.1038/news.2011.401.
  10. Graudal, N.; Jurgens, G.; Baslund, B.; Alderman, M. H. (26 March 2014). "Compared With Usual Sodium Intake, Low- and Excessive-Sodium Diets Are Associated With Increased Mortality: A Meta-Analysis". American Journal of Hypertension 27 (9): 1129–1137. doi:10.1093/ajh/hpu028. PMID 24651634.
  11. Bakalar, Nicholas (22 April 2014). "Study Linking Illness and Salt Leaves Researchers Doubtful". New York Times. Retrieved 24 November 2014.
  12. "Reduced salt intake critical, American Heart Association says". AHA Blog. 1 April 2014. Retrieved 24 November 2014.

External links